
Tempest Pharmaceuticals Private Limited
About Tempest Pharmaceuticals Private Limited
Data last updated:
Tempest Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 25 May 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB2007PTC116075.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Buddhadeb Chakraborty and Rishab Jaiswal.
Its last annual general meeting (AGM) was held on 28 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground Floor 124 Dakshin Para Road, Kolkata, West Bengal, India – 700028.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.73 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹648 (net margin 0.1%) and EBITDA of ₹770 (EBITDA margin 0.1%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 5% over five years.
Court records list 2 cases involving the company, including 2 filed by the company.
Company details
Contact details
Tempest Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal.
- Registered AddressGround Floor 124 Dakshin Para Road, Kolkata, West Bengal, India – 700028
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Tempest Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Tempest Pharmaceuticals Private Limited, buy the company report.
Financials of Tempest Pharmaceuticals Private Limited
FY 2025 filings availableTempest Pharmaceuticals Private Limited reported revenue of ₹9.73 Lakh (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 10% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹770 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹648 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.1% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tempest Pharmaceuticals Private Limited, buy the company report.
Board of directors of Tempest Pharmaceuticals Private Limited
Tempest Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Buddhadeb Chakraborty Also directs: Shivam Formulation Private Limited, Sars Surya Construction Private Limited, Omkarnath Merchants Private Limited and 3 more | Director | 10 Jun 2023 | 3 Years 4 Months | Current |
| Rishab Jaiswal Also directs: Shivam Formulation Private Limited, Sars Surya Construction Private Limited, Omkarnath Merchants Private Limited and 5 more | Director | 10 Jun 2023 | 3 Years 4 Months | Current |
Peer comparison
Tempest Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anuriuswell Pharmaceuticals Priavte Limited | ₹9.77 Lakh (FY 2020) | Pune, Maharashtra, India | ||||
| Dweps Pharmaceuticals Private Limited | ₹9.77 Lakh (FY 2024) | 413.0% | Jamshedpur, Jharkhand, India | |||
| Tempest Pharmaceuticals Private Limitedthis company | ₹9.73 Lakh (FY 2025) | ₹648 | 0.1% | 10.0% | Kolkata, West Bengal, India | |
| Yagmi Pharmaceuticals Private Limited | ₹9.73 Lakh (FY 2019) | 1956.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Tempest Pharmaceuticals Private Limited, buy the company report.
Legal cases
Tempest Pharmaceuticals Private Limited has 2 court cases on record: 2 filed by Tempest Pharmaceuticals. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Kolkata | Company petition | Filed by the company against Registrar of Companies Ministry of Corporate Affairs West Bengal | Disposed |
| High Court | Company petition | Filed by the company against The Registrar of Companies ,West Bengal | Disposed |
To see the full case history of Tempest Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tempest Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Tempest Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Tempest Pharmaceuticals Private Limited has 4 board changes on record since 2023: 2 appointments and 2 cessations. The latest: Kanhaiya Kumar ceased to be Director on 26 Jun 2023.
Frequently asked questions
Tempest Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 25 May 2007 (19+ years old) and is registered under CIN U24232WB2007PTC116075.
Tempest Pharmaceuticals has 2 current directors:
- Buddhadeb Chakraborty - Director
- Rishab Jaiswal - Director
The latest financial statements of Tempest Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 August 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Tempest Pharmaceuticals is U24232WB2007PTC116075. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tempest Pharmaceuticals has 2 court cases on record: 2 filed by the company. Most are in the high courts.
Tempest Pharmaceuticals was incorporated on 25 May 2007, making it 19+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Tempest Pharmaceuticals by revenue are Anuriuswell Pharmaceuticals Priavte Limited, Dweps Pharmaceuticals Private Limited, Yagmi Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).
Kanhaiya Kumar ceased to be Director on 26 Jun 2023. Mukesh Shaw ceased to be Director on 26 Jun 2023. Buddhadeb Chakraborty was appointed as Director on 10 Jun 2023. Tempest Pharmaceuticals has 4 board changes on record in total.
The registered office of Tempest Pharmaceuticals is at Ground Floor 124 Dakshin Para Road, Kolkata, West Bengal, India – 700028.
Tempest Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Tempest Pharmaceuticals can be reached at its registered office: Ground Floor 124 Dakshin Para Road, Kolkata, West Bengal, India – 700028.

